These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6159782)

  • 1. Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1980 Jan; 48(1):65-7. PubMed ID: 6159782
    [No Abstract]   [Full Text] [Related]  

  • 2. Isocitrate dehydrogenase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Leus R; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Jan; 49(1):61-3. PubMed ID: 6163342
    [No Abstract]   [Full Text] [Related]  

  • 3. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
    Yeshowardhana
    Indian J Physiol Pharmacol; 1985; 29(1):33-8. PubMed ID: 2414222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum aldolase in prostatic cancer].
    Maganto-Pavón E; Isorna S; Navajo-Galindo JA; Daimiel-Fernández ER; Martínez-Piñeiro JA
    Actas Urol Esp; 1979; 3(4):227-30. PubMed ID: 484308
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary enzymatic studies of human benign prostate hypertrophy and prostatic cancer.
    Miller HC; Rector W; Hilf R
    Invest Urol; 1972 Jul; 10(1):1-4. PubMed ID: 4114027
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
    Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
    Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On serum aldolase activity in carcinomas of the prostate].
    Frugoni A; Chianta A
    Minerva Urol; 1968; 20(1):1-4. PubMed ID: 5738630
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of serum aldolase in the early diagnosis of prostatic carcinoma].
    Maganto Pavón E; Daimiel Fernández ER; Navajo Lindo JA; Isorna S; Martínez Piñeiro JA
    Rev Clin Esp; 1979 Feb; 152(3):227-30. PubMed ID: 441476
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the usefulness of exploring enzymatic activities in prostatic carcinomas].
    Palazzotto G; Lattuca C
    Minerva Urol; 1969; 21(1):16-20. PubMed ID: 4321991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
    Zang T; Sun F; Li Y
    Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
    Damle SR; Talavdekar RV; Panse TB
    Indian J Cancer; 1971 Sep; 8(3):176-84. PubMed ID: 5141722
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the enzymatic and hemocoagulative changes in experimental induction of prostatic cancer in albino rats].
    Ronzoni G; Pola P; Fianchini A; Maisano A
    Chir Patol Sper; 1968 Feb; 6():Suppl 6:39-45. PubMed ID: 4194260
    [No Abstract]   [Full Text] [Related]  

  • 17. [The value of enzyme determinations in the differential diagnosis of prostatic hypertrophy and carcinoma. Parallel evaluation of the behavior of acid phosphatases, aldolase, malic and lactic dehydrogenases].
    FILIPAZZI A; LABORANTI F
    Riv Patol Clin; 1961 Dec; 16():787-96. PubMed ID: 13892860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of determining prostatic acid phosphatases by a radioimmunological method in cases of bony metastases].
    Mattei JP; Imbert I; Laugier-Catenacci E; Roux H
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):147-9. PubMed ID: 2471253
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
    Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
    Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [LDH index in the diagnosis of prostatic diseases].
    Lalanne MG; De Santis P; Mazzuca A
    Minerva Urol; 1983; 35(4):243-5. PubMed ID: 6201706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.